Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bellus Health Inc (BLU)

Bellus Health Inc (BLU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...

BLU : 14.74 (unch)
GSK.LN : 1,708.600 (+0.20%)
GSK : 42.87 (-0.28%)
BLU.TO : 19.48 (-0.10%)
Biotech ETFs Pop on M&A Resurgence

2023 could be a year of heightened biotech dealmaking activity

GSK : 42.87 (-0.28%)
NVS : 96.73 (+0.89%)
PFE : 27.75 (-0.11%)
MRK : 131.95 (+0.15%)
AMGN : 284.32 (-0.69%)
GILD : 73.25 (+0.33%)
VRTX : 418.01 (+0.17%)
IBB : 137.22 (-0.41%)
SGEN : 228.74 (-0.07%)
RXDX : 199.92 (+0.09%)
XBI : 94.89 (-0.02%)
SBIO : 35.75 (+0.42%)
Should You Buy Bellus Health (BLU) After Golden Cross?

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

BLU : 14.74 (unch)
BELLUS Health Announces Meeting Updates

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“ BELLUS Health ” or the “ Company ”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...

BLU : 14.74 (unch)
BLU.TO : 19.48 (-0.10%)
3 Biotechs That Might Get Bought Out in 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
MRK : 131.95 (+0.15%)
PFE : 27.75 (-0.11%)
GSK : 42.87 (-0.28%)
MDGL : 267.04 (+3.18%)
AMLX : 2.84 (-1.39%)
AUPH : 5.01 (+0.20%)
Was This Acquisition a Savvy Play by This Big Pharma Stock?

The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health.

GSK : 42.87 (-0.28%)
BLU : 14.74 (unch)
MRK : 131.95 (+0.15%)
Moore Kuehn Encourages BLU, STSA, RXDX, STSA, and CHRA Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

BLU : 14.74 (unch)
STSA : 1.1000 (-0.90%)
RXDX : 199.92 (+0.09%)
Why This Nasdaq Stock Caught Fire This Week

A wave of bargain buying benefited the gene therapy company's shares this week.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
TNYA : 5.23 (+1.36%)
Why Shares of Bellus Health Skyrocketed This Week

The company has received a buyout offer from GSK.

BLU : 14.74 (unch)
GSK : 42.87 (-0.28%)
MRK : 131.95 (+0.15%)
Bellus Health (BLU) Stock Up 99% on $2B Buyout Offer From GSK

Bellus Health (BLU) gets an offer to be acquired by pharma bigwig, GSK for an approximate total equity value of $2 billion. The stock is up 99%, following the news.

GSK : 42.87 (-0.28%)
ACAD : 18.49 (+1.59%)
APTX : 0.0960 (+3.11%)
BLU : 14.74 (unch)

Barchart Exclusives

Ford Motor vs. Toyota: Which Hybrid EV Stock Is a Better Buy?
With hybrid EVs gaining popularity, let’s find out whether shares of Ford or Toyota are a better buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar